Lv5
890 积分 2025-10-09 加入
Residue-Specific Impact of EDTA and Methionine on Protein Oxidation in Biotherapeutics Formulations Using an Integrated Biotherapeutics Drug Product Development Workflow
19天前
已完结
Formulation Development for Antibody–Drug Conjugates
21天前
已完结
Histidine as a versatile excipient in the protein-based biopharmaceutical formulations
21天前
已完结
FDA approved PFS-based autoinjectors: evolution, market trends, and development challenges
1个月前
已完结
Overview of Analytical Methods for Characterizing the Charge Heterogeneity of Antibody-Drug Conjugates
3个月前
已关闭
Effect of Conjugation Site and Technique on the Stability and Pharmacokinetics of Antibody-Drug Conjugates
3个月前
已完结
A comprehensive review of key factors affecting the efficacy of antibody drug conjugate
3个月前
已完结
Stabilizing a Tubulysin Antibody–Drug Conjugate To Enable Activity Against Multidrug-Resistant Tumors
4个月前
已完结
Protein L chromatography: A useful tool for monitoring/separating homodimers during the purification of IgG-like asymmetric bispecific antibodies
4个月前
已关闭
To platform or not to platform: Strategic considerations for antibody formulation in early clinical development
4个月前
已完结
皖公网安备34019202002308
